Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

1.

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.

Rosso-Fernández C, Sojo-Dorado J, Barriga A, Lavín-Alconero L, Palacios Z, López-Hernández I, Merino V, Camean M, Pascual A, Rodríguez-Baño J; FOREST Study Group.

BMJ Open. 2015 Mar 31;5(3):e007363. doi: 10.1136/bmjopen-2014-007363.

2.

Prospective multicenter study of carbapenemase producing Enterobacteriaceae from 83 hospitals in Spain: High in vitro susceptibility to colistin and meropenem.

Oteo J, Ortega A, Bartolomé R, Bou G, Conejo C, Fernández-Martínez M, González-López JJ, Martínez-García L, Martínez-Martínez L, Merino M, Miró E, Mora M, Navarro F, Oliver A, Pascual Á, Rodríguez-Baño J, Ruiz-Carrascoso G, Ruiz-Garbajosa P, Zamorano L, Bautista V, Pérez-Vázquez M, Campos J; GEIH-GEMARA (SEIMC) and REIPI.

Antimicrob Agents Chemother. 2015 Mar 30. pii: AAC.00086-15. [Epub ahead of print]

PMID:
25824224
3.

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.

Shaw E, Miró JM, Puig-Asensio M, Pigrau C, Barcenilla F, Murillas J, Garcia-Pardo G, Espejo E, Padilla B, Garcia-Reyne A, Pasquau J, Rodriguez-Baño J, López-Contreras J, Montero M, de la Calle C, Pintado V, Calbo E, Gasch O, Montejo M, Salavert M, Garcia-Pais MJ, Carratalà J, Pujol M; Spanish Network for Research in Infectious Diseases (REIPI RD12/0015); Instituto de Salud Carlos III, Madrid, Spain; GEIH (Hospital Infection Study Group).

BMJ Open. 2015 Mar 11;5(3):e006723. doi: 10.1136/bmjopen-2014-006723.

4.

In reply--What is the optimal timing for surgical treatment of infective endocarditis?

Gálvez-Acebal J, Almendro-Delia M, Rodriguez-Baño J.

Mayo Clin Proc. 2015 Mar;90(3):415-6. doi: 10.1016/j.mayocp.2014.12.017. No abstract available.

PMID:
25744119
5.

Effects of isolation on patients and staff.

Lupión-Mendoza C, Antúnez-Domínguez MJ, González-Fernández C, Romero-Brioso C, Rodriguez-Bano J.

Am J Infect Control. 2015 Apr 1;43(4):397-9. doi: 10.1016/j.ajic.2015.01.009. Epub 2015 Feb 24.

PMID:
25721058
6.

European survey on principles of prudent antibiotic prescribing teaching in undergraduate students.

Pulcini C, Wencker F, Frimodt-Møller N, Kern WV, Nathwani D, Rodríguez-Baño J, Simonsen GS, Vlahović-Palčevski V, Gyssens IC; for the ESGAP Curriculum Working Group.

Clin Microbiol Infect. 2014 Nov 22. pii: S1198-743X(14)00101-3. doi: 10.1016/j.cmi.2014.11.015. [Epub ahead of print]

PMID:
25658523
7.

Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology.

Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G; for the Study Group of Nosocomial Infections (GEIH) of the Spanish Society of Infectious Diseases, Infectious Diseases (SEIMC).

Enferm Infecc Microbiol Clin. 2015 Jan 15. pii: S0213-005X(14)00390-5. doi: 10.1016/j.eimc.2014.11.009. [Epub ahead of print]

PMID:
25600218
8.

Lessons from an outbreak of metallo-β-lactamase-producing Klebsiella oxytoca in an intensive care unit: the importance of time at risk and combination therapy.

Vergara-López S, Domínguez MC, Conejo MC, Pascual Á, Rodríguez-Baño J.

J Hosp Infect. 2015 Feb;89(2):123-31. doi: 10.1016/j.jhin.2013.12.008. Epub 2014 Jan 15.

PMID:
25595832
9.

Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G; for the Study Group of Nosocomial Infections (GEIH) of the Spanish Society of Infectious Diseases, Infectious Diseases (SEIMC).

Enferm Infecc Microbiol Clin. 2015 Jan 3. pii: S0213-005X(14)00397-8. doi: 10.1016/j.eimc.2014.11.015. [Epub ahead of print]

PMID:
25563393
10.

Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.

Rodríguez-Baño J, Cisneros JM, Gudiol C, Martínez JA.

Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:49-55. doi: 10.1016/S0213-005X(14)70174-0.

PMID:
25542052
11.

Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?

Pascual Á, Pintado V, Rodríguez-Baño J, Miró JM.

Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:1-3. doi: 10.1016/S0213-005X(14)70167-3.

PMID:
25542045
12.

Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain.

López-Cerero L, Egea P, Gracia-Ahufinger I, González-Padilla M, Rodríguez-López F, Rodríguez-Baño J, Pascual A.

Int J Antimicrob Agents. 2014 Dec;44(6):538-40. doi: 10.1016/j.ijantimicag.2014.08.006. Epub 2014 Sep 26.

PMID:
25446907
13.

Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.

Peña C, Cabot G, Gómez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E, Rodríguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases (REIPI).

Clin Infect Dis. 2015 Feb 15;60(4):539-48. doi: 10.1093/cid/ciu866. Epub 2014 Nov 6.

PMID:
25378459
14.

Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.

Gonzalez-Padilla M, Torre-Cisneros J, Rivera-Espinar F, Pontes-Moreno A, López-Cerero L, Pascual A, Natera C, Rodríguez M, Salcedo I, Rodríguez-López F, Rivero A, Rodríguez-Baño J.

J Antimicrob Chemother. 2015 Mar;70(3):905-13. doi: 10.1093/jac/dku432. Epub 2014 Oct 25.

PMID:
25344809
15.

Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: impact of antimicrobial resistance in a large hospitalised cohort.

Shaw E, Benito N, Rodríguez-Baño J, Padilla B, Pintado V, Calbo E, Pallarés MA, Gozalo M, Ruiz-Garbajosa P, Horcajada JP; REIPI/ITUBRAS-GEIH group, Spain.

J Infect. 2015 Mar;70(3):247-54. doi: 10.1016/j.jinf.2014.09.011. Epub 2014 Oct 12.

PMID:
25305497
16.

Dalbavancin or oritavancin for skin infections.

Núñez-Núñez M, Rodríguez-Baño J.

N Engl J Med. 2014 Sep 18;371(12):1160. doi: 10.1056/NEJMc1407925#SA1. No abstract available.

PMID:
25229923
17.

Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca.

Vergara-López S, Domínguez MC, Conejo MC, Pascual Á, Rodríguez-Baño J.

J Antimicrob Chemother. 2015 Jan;70(1):313-5. doi: 10.1093/jac/dku341. Epub 2014 Sep 1. No abstract available.

PMID:
25182061
18.

Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.

Villar M, Cano ME, Gato E, Garnacho-Montero J, Miguel Cisneros J, Ruíz de Alegría C, Fernández-Cuenca F, Martínez-Martínez L, Vila J, Pascual A, Tomás M, Bou G, Rodríguez-Baño J; GEIH/GEMARA/REIPI-Ab20101 Group.

Medicine (Baltimore). 2014 Jul;93(5):202-10. doi: 10.1097/MD.0000000000000036.

PMID:
25181313
19.

Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: a multicenter cohort study.

Gálvez-Acebal J, Almendro-Delia M, Ruiz J, de Alarcón A, Martínez-Marcos FJ, Reguera JM, Ivanova-Georgieva R, Noureddine M, Plata A, Lomas JM, de la Torre-Lima J, Hidalgo-Tenorio C, Luque R, Rodríguez-Baño J; Study Group for Cardiovascular Infections, part of the Andalusian Society of Infectious Diseases.

Mayo Clin Proc. 2014 Oct;89(10):1397-405. doi: 10.1016/j.mayocp.2014.06.021. Epub 2014 Aug 30.

PMID:
25178264
20.

Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.

Machuca J, Briales A, Labrador G, Díaz-de-Alba P, López-Rojas R, Docobo-Pérez F, Martínez-Martínez L, Rodríguez-Baño J, Pachón ME, Pascual A, Rodríguez-Martínez JM.

J Antimicrob Chemother. 2014 Dec;69(12):3203-15. doi: 10.1093/jac/dku308. Epub 2014 Aug 19.

PMID:
25139837
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk